Minireview: Regulation of Gene Expression by Nuclear Hormone Receptors

References

• Amero S. A., Kretsinger R. H., Moncrief N. D., Yamamoto K. R., Pearson W. R. The origin of nuclear receptor proteins: A single precursor distinct from other transcription factors. Mol. Endocrinol. 1992; 6: 3–7
   PubMedGoogle Scholar
• Stunnenberg H. G. Mechanisms of transactivation by retinoic acid receptors. BioEssays 1993; 15: 309–315
   PubMed Web of Science ®Google Scholar
• Mangelsdorf D. J., Evans R. M. The RXR heterodimers and orphan receptors. Cell 1995; 83: 841–850
   PubMed Web of Science ®Google Scholar
• Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 1995; 375: 377–382
   PubMed Web of Science ®Google Scholar
• Renaud J. P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 1995; 378: 681–689
   PubMed Web of Science ®Google Scholar
• Wagner R. L., Apriletti J. W., McGrath M. E., West B. L., Baxter J. D., Fletterick R. J. A structural role for hormone in the thyroid hormone receptor. Nature 1995; 378: 690–697
   PubMed Web of Science ®Google Scholar
• Smith D. F., Toft D. O. Steroid receptors and their associated proteins. Mol. Endocrinol. 1993; 7: 4–10
   PubMed Web of Science ®Google Scholar
• Perlmann T., Vennström B. The sound of silence. Nature 1995; 377: 387–388
   PubMed Web of Science ®Google Scholar
• Lee J. W., Ryan F., Swaffield J. C., Johnston S. A., Moore D. D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 1995; 374: 91–94
   PubMed Web of Science ®Google Scholar
• Baur E. V., Zechel C., Heery D., Heine M. J. S., Garnier J. M., Vivat V., Le Douarin B., Gronemeyer H., Chambon P., Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUGl and TIF1. EMBO J. 1996; 15: 110–124
   PubMed Web of Science ®Google Scholar
• Cavailles V., Dauvois S., Danielian P. S., Parker M. G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA 1994; 91: 10009–10013
   PubMed Web of Science ®Google Scholar
• Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C., Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 1994; 264: 1455–1458
   PubMed Web of Science ®Google Scholar
• Onate S. A., Tsai S. Y., Tsai M. J., O'Malley B. W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995; 270: 1354–1357
   PubMed Web of Science ®Google Scholar
• Straehle U., Boshart M., Klock G., Stewart F., Schütz G. Glucocorticoid and progesterone-specific effects are determined by differential expression of the respective hormone receptors. Nature 1989; 339: 629–632
   PubMed Web of Science ®Google Scholar
• Funder J. W., Pearce P. T., Smith R., Smith A. I. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242: 583–585
   PubMed Web of Science ®Google Scholar
• Umesono K., Murakami K. K., Thompson C. C., Evans R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991; 65: 1255–1266
   PubMed Web of Science ®Google Scholar
• Rastinejad F., Perlmann T., Evans R. M., Sigler P. B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 1995; 375: 203–211
   PubMed Web of Science ®Google Scholar
• Forman B. M., Umesono K., Chen J., Evans R. M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 1995; 81: 541–550
   PubMed Web of Science ®Google Scholar
• Yao T. P., Forman B. M., Jiang Z. Y., Cherbas L., Chen J. D., McKeown M., Cherbas P., Evans R. M. Functional ecdysone receptor is the product of EcR and ultraspiracle genes. Nature 1993; 366: 476–479
   PubMed Web of Science ®Google Scholar
• Forman B. M., Goode E., Chen J., Oro A. E., Bradley D. J., Perlmann T., Noonan D. J., Burka L. T., McMorris T., Lamph W. W., Evans R. M., Weinberger C. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995; 81: 687–693
   PubMed Web of Science ®Google Scholar
• Keller H., Wahli W. Peroxisome proliferator-activated receptors – a link between endocrinology and nutrition. Trends. Endocrinol. Metab. 1993; 4: 291–296
   PubMed Web of Science ®Google Scholar
• Green S., Wahli W. Peroxisome proliferator-activated receptors: finding the orphan a home. Mol. Cell. Endocrinol. 1994; 100: 149–153
   PubMed Web of Science ®Google Scholar
• Tontonoz P., Hu E., Spiegelman B. M. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 1995; 5: 571–576
   PubMed Web of Science ®Google Scholar
• Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARgamma). J. Biol. Chem. 1995; 270: 12953–12956
   PubMed Web of Science ®Google Scholar
• Kliewer S. A., Lenhard J. M., Willson T. M., Patel I., Morris D. C., Lehmann J. M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995; 83: 813–819
   PubMed Web of Science ®Google Scholar
• Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M. 15-Deoxy-Delta12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARgamma. Cell 1995; 83: 803–812
   PubMed Web of Science ®Google Scholar
• Spitz I. M., Bardin C. W. Mifepristone (RU 486) – A modulator of progestin and glucocorticoid action. N. Engl. J. Med. 1993; 329: 404–412
   PubMed Web of Science ®Google Scholar
• Katzenellenbogen J. A., O'Malley B. W., Katzenellenbogen B. S. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 1996; 10: 119–131
   PubMed Web of Science ®Google Scholar
• Pfahl M. Nuclear receptor/AP-1 interaction. Endocr. Rev. 1993; 14: 651–658
   PubMed Web of Science ®Google Scholar
• Juge-Aubry C. E., Gorla-Bajszczak A., Pernin A., Lemberger T., Wahli W., Burger A., Meier C. A. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. J. Biol. Chem. 1995; 270: 18117–18122
   PubMed Web of Science ®Google Scholar
• Kraus W. L., Weis K. E., Katzenellenbogen B. S. Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol. Cell Biol. 1995; 15: 1847–1857
   PubMed Web of Science ®Google Scholar
• Kuiper G. G., Brinkmann A. O. Steroid hormone receptor phosphorylation: is there a physiological role?. Mol. Cell. Endocrinol. 1994; 100: 103–107
   PubMed Web of Science ®Google Scholar
• Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995; 270: 1491–1494
   PubMed Web of Science ®Google Scholar
• Quigley C. A., De Bellis A., Marschke K. B., el-Awady M. K., Wilson E. M., French F. S. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev. 1995; 16: 271–321
   PubMed Web of Science ®Google Scholar
• Smith E. P., Boyd J., Frank G. R., Takahashi H., Cohen R. M., Specker B., Williams T. C., Lubahn D. B., Korach K. S. Estrogen resistance caused by a mutation in the estrogen- receptor gene in a man. N. Engl. J. Med. 1994; 331: 1056–1061
   PubMed Web of Science ®Google Scholar
• Meier C. A., Parkison C., Chen A., Ashizawa K., Meier-Heusler S. C., Muchmore P., Cheng S. Y., Weintraub B. D. Interaction of human beta-1 thyroid hormone receptor and its mutants with DNA and retinoid-X receptor-beta: T3 response element dependent dominant negative potency. J. Clin. Invest 1993; 92: 1986–1993
   PubMed Web of Science ®Google Scholar
• Yen P. M., Chin W. W. Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol. Endocrinol. 1994; 8: 1450–1454
   PubMedGoogle Scholar
• Taplin M. E., Bubley G. J., Shuster T. D., Frantz M. E., Spooner A. E., Ogata G. K., Keer H. N., Balk S. P. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer [see comments]. N. Engl. J. Med. 1995; 332: 1393–1398
   PubMed Web of Science ®Google Scholar
• Visakorpi T., Hyytinen E., Koivisto P., Tanner M., Keinänen R., Palmberg C., Palotie A., Tammela T., Isola J., Kallioniemi O.-P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet. 1995; 9: 401–406
   PubMed Web of Science ®Google Scholar
• Horwitz K. B. How do breast cancers become hormone resistant. J. Steroid Biochem. Mol. Biol. 1994; 49: 295–302
   PubMed Web of Science ®Google Scholar
• Mahfoudi A., Roulet E., Dauvois S., Parker M. G., Wahli W. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc. Natl. Acad. Sci. USA 1995; 92: 4206–4210
   PubMed Web of Science ®Google Scholar
• Strasser-Wozak E. M., Hattmannstorfer R., Hala M., Hartmann B. L., Fiegl M., Geley S., Kofler R. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res. 1995; 55: 348–353
   PubMed Web of Science ®Google Scholar
• Agadir A., Cornic M., Gourmel B., Lefebvre P., Degos L., Chomienne C. Review: Retinoic acid receptors: Involvement in acute promyelocytic leukemia. Cell Mol. Biol. 1994; 40: 263–274
   PubMed Web of Science ®Google Scholar
• Chen Z., Guidez F., Rousselot P., Agadir A., Chen S. J., Wang Z. Y., Degos L., Zelent A., Waxman S., Chomienne C. PLZF-RAR alpha fusion proteins generated from the variant t(11–17)(q23–q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild- type retinoic acid receptors. Proc. Natl. Acad. Sci. USA 1994; 91: 1178–1182
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Dethe H., Wang Z. Y., Degos L. Acute promyelocytic leukemia. N. Engl. J. Med. 1993; 329: 177–189
   PubMed Web of Science ®Google Scholar